The zebrafish, Danio rerio, has become recognized as a valuable model for infectious diseases. Here we evaluated the susceptibility of zebrafish to be infected with the mammalian vesicular stomatitis virus (VSV). Both zebrafish cells and embryos were highly susceptible to VSV infection. Mortalities exceeded 80% in infected embryos and were preceded by the invasion of the central nervous system by VSV. Live imaging of the infection with GFP-VSV as well as virus titration from infected fish confirmed the viral replication. Immunohistochemical analysis of embryonic fish provided evidence of viral antigens as well as of the apoptosis marker caspase-3 in the brain, eye, liver, pronephros, and skeletal muscle. So far, this is the first report describing the susceptibility of zebrafish to the mammalian virus VSV.
Get full access to this article
View all access options for this article.
References
1.
ClarkeDK, HendryRM, SinghV, RoseJK, SeligmanSJ, KlugB, et al.Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: standardized template with key considerations for a risk/benefit assessment. Vaccine, 2016; 34:6597–6609.
2.
FarooqF, BeckK, PaolinoKM, PhillipsR, WatersNC, RegulesJA, et al.Circulating follicular T helper cells and cytokine profile in humans following vaccination with the rVSV-ZEBOV Ebola vaccine. Sci Rep, 2016; 6:27944.
3.
HastieE, GrdzelishviliVZ. Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer. J Gen Virol, 2012; 93:2529–2545.
4.
ZhangL, SteeleMB, JenksN, GrellJ, BehrensM, NaceR, et al.Robust oncolytic virotherapy induces tumor lysis syndrome and associated toxicities in the MPC-11 plasmacytoma model. Mol Ther, 2016; 24:2109–2117.
WilkinsC, DishonghR, MooreSC, WhittMA, ChowM, MachacaK. RNA interference is an antiviral defence mechanism in Caenorhabditis elegans. Nature, 2005; 436:1044–1047.
7.
Baz-MartínezM, Da Silva-ÁlvarezS, RodríguezE, GuerraJ, El MotiamA, VidalA, et al.Cell senescence is an antiviral defense mechanism. Sci Rep, 2016; 6:37007.
8.
Munoz-FontelaC, GarciaMA, Garcia-CaoI, ColladoM, ArroyoJ, EstebanM, et al.Resistance to viral infection of super p53 mice. Oncogene, 2005; 24:3059–3062.
9.
Marcos-VillarL, Perez-GironJV, VilasJM, SotoA, de la Cruz-HererraCF, LangV, et al.SUMOylation of p53 mediates interferon activities. Cell Cycle, 2013; 12:2809–2816.
10.
DonaldsonAI, FerrisNP. Vesicular stomatitis. Equine Vet Educ, 1995; 7:205–207.
11.
MeadDG, RambergFB, BesselsenDG, MaréCJ. Transmission of vesicular stomatitis virus from infected to noninfected black flies co-feeding on nonviremic deer mice. Science, 2000; 287:485–487.
12.
ZimmerB, SummermatterK, ZimmerG. Stability and inactivation of vesicular stomatitis virus, a prototype rhabdovirus. Vet Microbiol, 2013; 162:78–84.
13.
FieldsBN, HawkinsK. Human infection with the virus of vesicular stomatitis during an epizootic. N Engl J Med, 1967; 277:989–994.
14.
HubálekZ, RudolfI, NowotnyN. Arboviruses pathogenic for domestic and wild animals. Adv Virus Res, 2014; 89:201–275.
15.
LetchworthGJ, RodriguezLL, Del cbarreraJ. Vesicular stomatitis. Vet J, 1999; 157:239–260.
16.
QuirozE, MorenoN, PeraltaPH, TeshRB. A human case of encephalitis associated with vesicular stomatitis-virus (Indiana serotype) infection. Am J Trop Med Hyg, 1988; 39:312–314.
17.
GagnidzeK, HajdarovicKH, MoskalenkoM, KaratsoreosIN, McEwenBS, BullochK. Nuclear receptor REV-ERBα mediates circadian sensitivity to mortality in murine vesicular stomatitis virus-induced encephalitis. Proc Natl Acad Sci U S A, 2016; 113:5730–5735.
CrimMJ, RileyLK. Viral diseases in zebrafish: what is known and unknown. ILAR J, 2012; 53:135–143.
20.
VarelaM, FiguerasA, NovoaB. Modelling viral infections using zebrafish: innate immune response and antiviral research. Antivir Res, 2017; 139:59–68.
21.
SandersGE, BattsWN, WintonJR. Susceptibility of zebrafish (Danio rerio) to a model pathogen, spring viremia of carp virus. Comp Med, 2003; 53:514–521.
22.
PhelanPE, PressleyME, WittenPE, MellonMT, BlakeS, KimCH. Characterization of snakehead rhabdovirus infection in zebrafish (Danio rerio) characterization of snakehead rhabdovirus infection in zebrafish (Danio rerio). J Virol, 2005; 79:1842–1852.
23.
NovoaB, RomeroA, MuleroV, RodríguezI, FernándezI, FiguerasA. Zebrafish (Danio rerio) as a model for the study of vaccination against viral haemorrhagic septicemia virus (VHSV). Vaccine, 2006; 24:5806–5816.
24.
LuMW, ChaoYM, GuoTC, SantiN, EvensenØ, KasaniSK, et al.The interferon response is involved in nervous necrosis virus acute and persistent infection in zebrafish infection model. Mol Immunol, 2008; 45:1146–1152.
25.
XuXP, ZhangLC, WengSP, HuangZJ, LuJ, LanDM, et al.A zebrafish (Danio rerio) model of infectious spleen and kidney necrosis virus (ISKNV) infection. Virology, 2008; 376:1–12.
26.
AggadD, MazelM, BoudinotP, MogensenKE, HammingOJ, HartmannR, et al.The two groups of zebrafish virus-induced interferons signal via distinct receptors with specific and shared chains. J Immunol, 2009; 183:3924–3931.
27.
López-MuñozA, RocaFJ, SepulcreMP, MeseguerJ, MuleroV. Zebrafish larvae are unable to mount a protective antiviral response against waterborne infection by spring viremia of carp virus. Dev Comp Immunol, 2010; 34:546–552.
28.
LudwigM, PalhaN, TorhyC, BriolatV, Colucci-GuyonE, BremontM, et al.Whole-body analysis of a viral infection: vascular endothelium is a primary target of infectious hematopoietic necrosis virus in zebrafish larvae. PLoS Pathog, 2011; 7:e1001269.
29.
VarelaM, RomeroA, DiosS, Van Der VaartM, FiguerasA, MeijerAH, et al.Cellular visualization of macrophage pyroptosis and interleukin-1β release in a viral hemorrhagic infection in zebrafish larvae. J Virol, 2014; 88:12026–12040.
30.
MartinV, MavianC, Lopez BuenoA, de MolinaA, DiazE, AndresG, et al.Establishment of a zebrafish infection model for the study of wild-type and recombinant European sheatfish virus. J Virol, 2015; 89:10702–10706.
31.
PalhaN, Guivel-BenhassineF, BriolatV, LutfallaG, SourisseauM, EllettF, et al.Real-time whole-body visualization of chikungunya virus infection and host interferon response in zebrafish. PLoS Pathog, 2013; 9:e1003619.
GaborKA, GoodyMF, MowelWK, BreitbachME, GratacapRL, WittenPE, et al.Influenza A virus infection in zebrafish recapitulates mammalian infection and sensitivity to anti-influenza drug treatment. Dis Model Mech, 2014; 7:1227–1237.
34.
LiuW, ChenJR, HsuCH, LiYH, ChenYM, LinCY, et al.A zebrafish model of intrahepatic cholangiocarcinoma by dual expression of hepatitis B virus X and hepatitis C virus core protein in liver. Hepatology, 2012; 56:2268–2276.
35.
DingCB, ZhangJP, ZhaoY, PengZG, SongDQ, JiangJD. Zebrafish as a potential model organism for drug test against hepatitis C virus. PLoS One, 2011; 6:e22921.
36.
WesterfieldM: The Zebrafish Book. A Guide for the Laboratory Use of Zebrafish (Danio rerio), 5th Edition. Univ Oregon Press Eugene, OR, 2007.
37.
EbertO, ShinozakiK, HuangT.Oncolytic vesicular stomatitis virus for treatment of orthotopic hepatocellular carcinoma in immune-competent rats oncolytic vesicular stomatitis virus for treatment of orthotopic hepatocellular. Cancer Res, 2003:63; 3605–3611.
38.
ReedLJ, MuenchH. A simple method of estimating fifty per cent endpoints. Am J Epidemiol, 1938; 27:493–497.
39.
SeoJ, YunCO, KwonOJ, ChoiEJ, SongJY, ChoiI, et al.A proteoliposome containing apolipoprotein a-i mutant (v156k) enhances rapid tumor regression activity of human origin oncolytic adenovirus in tumor-bearing zebrafish and mice. Mol Cells, 2012; 34:143–148.
40.
HuneycuttBS, PlakhovIV, ShustermanZ, BartidoSM, HuangA, ReissCS, et al.Distribution of vesicular stomatitis virus proteins in the brain of BALB/c mice following intranasal inoculation: an immunohistochemical analysis. Brain Res, 1994; 635:81–95.
41.
TrottierMD, DouglasSL, ReissCS. Peripheral, but not central nervous system, type I interferon expression in mice in response to intranasal vesicular stomatitis virus infection. J Neurovirol, 2007; 13:433–445.
42.
BalachandranS, PorosnicuM, BarberGN. Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or Myc function and involves the induction of apoptosis. J Virol, 2001; 75:3474–3479.
43.
KopeckySA, WillinghamMC, LylesDS. Matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus. J Virol, 2001; 75:12169–12181.
44.
KopeckySA, LylesDS. Contrasting effects of matrix protein on apoptosis in HeLa and BHK cells infected with vesicular stomatitis virus are due to inhibition of host gene expression. J Virol, 2003; 77:4658–4669.
45.
GaddyDF, LylesDS. Vesicular stomatitis viruses expressing wild-type or mutant M proteins activate apoptosis through distinct pathways. J Virol, 2005; 79:4170–4179.
46.
BurnsJC, FriedmannT, DrievertW, BurrascanoM, YeeJ-K. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells (gene therapy/zebrafish). Proc Natl Acad Sci U S A, 1993; 90:8033–8037.
47.
LinS, GaianoN, CulpP, BurnsJC, FriedmannT, YeeJK, et al.Integration and germ-line transmission of a pseudotyped retroviral vector in zebrafish. Science, 1994; 265:666–669.
48.
GaianoN, AmsterdamA, KawakamiK, AllendeM, BeckerT, HopkinsN. Insertional mutagenesis and rapid cloning of essential genes in zebrafish. Nature, 1996; 383:829–832.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
